Fundraising Fox

PharmaCann

Oak Park, US · Founded 2014 · 621 employees on LinkedIn · 1 known investors

PharmaCann is a vertically integrated cannabis company operating cultivation centers, product brands, and retail dispensaries (LivWell and Verilife) serving both medical patients and recreational customers in the United States. It develops and sells cannabis products across the wellness-focused cannabis industry.

BiotechConsumerRetail TechWellness & Fitness

Founders & leadership

PharmaCann was founded in 2014 by Teddy Scott and John A Leja.

TS
Teddy ScottinCo-founder
JA
John A LejainCo-founder
NS
Norah ScottinExecutive
BL
Brad LeshnockExecutive
CL
Christina LejaNamed on SEC filing

Board

SS
Stephen SchulerBoard director

Investors · 1

Artemis Growth PartnersLondon

Reported raises · per SEC filings

Form D private placements

$508.4M disclosed across 18 of 19 rounds · 2014–2024

▶$35MraisedApr 2024 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brett NoveyExecutive Officer, Director
  • Patrick UnzickerExecutive Officer
  • Robert McQueenExecutive Officer
  • James Patrick BarryDirector
  • Stephen SchulerDirector
  • Lori RichardsDirector
  • John McCarthyDirector
  • John LordDirector
Offering amount
$50M
Amount sold
$35M
Minimum investment
$1M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedApr 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brett NoveyExecutive Officer, Director
  • John McCarthyDirector
  • John LordDirector
  • Patrick UnzickerExecutive Officer
  • Lori RichardsDirector
  • James Patrick BarryDirector
  • Robert McQueenExecutive Officer
  • Stephen SchulerDirector
Offering amount
$10M
Amount sold
$10M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.9MraisedApr 2024 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen SchulerDirector
  • John McCarthyDirector
  • John LordDirector
  • Lori RichardsDirector
  • Brett NoveyExecutive Officer, Director
  • Patrick UnzickerExecutive Officer
  • Robert McQueenExecutive Officer
  • James Patrick BarryDirector
Offering amount
$18M
Amount sold
$12.9M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedApr 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • James Patrick BarryDirector
  • Patrick UnzickerExecutive Officer
  • John LordDirector
  • Stephen SchulerDirector
  • John McCarthyDirector
  • Robert McQueenExecutive Officer
  • Brett NoveyExecutive Officer, Director
  • Lori RichardsDirector
Offering amount
$7M
Amount sold
$7M
Sales commissions
$280K
Placement agents
Netshares Financial Services LLC
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.7MraisedApr 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Lori RichardsDirector
  • John LordDirector
  • Stephen SchulerDirector
  • Patrick UnzickerExecutive Officer
  • James Patrick BarryDirector
  • John McCarthyDirector
  • Robert McQueenExecutive Officer
  • Brett NoveyExecutive Officer, Director
Offering amount
$27.7M
Amount sold
$27.7M
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedApr 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert McQueenExecutive Officer
  • Stephen SchulerDirector
  • Lori RichardsDirector
  • James Patrick BarryDirector
  • Patrick UnzickerExecutive Officer
  • John McCarthyDirector
  • Brett NoveyExecutive Officer, Director
  • John LordDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$400K
Placement agents
Netshares Financial Services LLC
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedApr 2024 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Lori RichardsDirector
  • Patrick UnzickerExecutive Officer
  • Robert McQueenExecutive Officer
  • Brett NoveyExecutive Officer, Director
  • Stephen SchulerDirector
  • John LordDirector
  • John McCarthyDirector
  • James Patrick BarryDirector
Offering amount
$5M
Amount sold
$5M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedNov 2022 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert McQueenExecutive Officer
  • Daniel RothExecutive Officer
  • Lori RichardsDirector
  • John McCarthyDirector
  • James Patrick BarryDirector
  • John LordDirector
  • Stephen SchulerDirector
  • Patrick UnzickerExecutive Officer
  • Brett NoveyExecutive Officer, Director
  • David ChiovettiExecutive Officer
Offering amount
$25M
Amount sold
$2.2M
Minimum investment
$100K
Sales commissions
$36K
Placement agents
Netshares Financial Services LLC
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does PharmaCann do?
PharmaCann is a vertically integrated cannabis company operating cultivation centers, product brands, and retail dispensaries (LivWell and Verilife) serving both medical patients and recreational customers in the United States. It develops and sells cannabis products across the wellness-focused cannabis industry.
Who founded PharmaCann?
PharmaCann was founded by Teddy Scott, John A Leja in 2014.
Who are PharmaCann's investors?
PharmaCann's investors include Artemis Growth Partners.
How much funding has PharmaCann raised?
PharmaCann has disclosed $508.4M raised across 18 of its 19 known rounds.
Where is PharmaCann headquartered?
PharmaCann is headquartered in Oak Park, US.